Molecular 'on-off' switch for Parkinson's disease discovered

May 23, 2012

(Medical Xpress) -- Scientists at the Medical Research Council (MRC) Protein Phosphorylation Unit at the University of Dundee have discovered a new molecular switch that acts to protect the brain from developing Parkinson's disease.

The findings have helped scientists understand how in a gene called PINK1 lead to Parkinson's in patients as young as 8 years old - which could eventually lead to new ways to diagnose and treat the condition.

The job of some proteins inside cells is to switch other important proteins on or off. Understanding how these proteins work and which proteins they target could be the key to why die in Parkinson's - and how we can save them.

But despite intensive research, the target of the PINK1 enzyme (which is made by the PINK1 gene) has eluded scientists for almost a decade.

Now the Dundee team has found that PINK1 switches on a protein called , whose main job is to keep cells healthy by removing damaged proteins. Mutations in the gene that makes Parkin can also cause inherited forms of Parkinson's in younger patients .

The team was led jointly by Dr Miratul Muqit and Professor Dario Alessi at the University of Dundee.

"Parkinson's is a devastating and currently we have no drugs in the clinic that can cure or slow the disease down," said Dr Muqit, a Wellcome Trust Clinician Scientist in the MRC Unit.

"Over the last decade, many genes have been linked to Parkinson's but a major roadblock has been determining the function of these genes in the brain and how the mutations lead to brain degeneration."

Dr Muqit said, "Our work suggests this pathway can't be switched on in Parkinson's patients with genetic mutations in or Parkin. More research will be needed to see whether this also happens in Parkinson's patients who do not carry these mutations."

Professor Alessi, Director of the MRC Phosphorylation Unit, added, "Now that we have identified this pathway, the key next step will be to identify the nature of these damaged proteins that are normally removed by Parkin. Although further studies are required, our findings also suggest that designer drugs that switch this pathway on could be used to treat Parkinson's."

The research was funded by the Medical Research Council, Wellcome Trust, Parkinson's UK, the J. Macdonald Menzies Charitable Trust and the Michael J. Fox Foundation.

The research is published in the latest edition of the journal Open Biology. The paper was co-authored with Dr Helen Walden from Cancer Research UK's London Research Institute.

Explore further: Vitamin K2: New hope for Parkinson's patients?

Related Stories

Vitamin K2: New hope for Parkinson's patients?

May 11, 2012
Neuroscientist Patrik Verstreken, associated with VIB and KU Leuven, succeeded in undoing the effect of one of the genetic defects that leads to Parkinson's using vitamin K2. His discovery gives hope to Parkinson's patients. ...

Why do neurons die in Parkinson's disease?

November 10, 2011
Current thinking about Parkinson's disease is that it's a disorder of mitochondria, the energy-producing organelles inside cells, causing neurons in the brain's substantia nigra to die or become impaired. A study from Children's ...

Protein linked to Parkinson's disease may regulate fat metabolism

August 25, 2011
National Institutes of Health researchers have found that Parkin, an important protein linked with some cases of early-onset Parkinson's disease, regulates how cells in our bodies take up and process dietary fats.

Recommended for you

Good cells gone bad: Scientists discover PINK-SNO

November 21, 2017
A new study from The Scripps Research Institute (TSRI) is the first to show precisely how a process in nerve cells called the S-nitrosylation (SNO) reaction—which can be caused by aging, pesticides and pollution—may contribute ...

Genetic defects in the cell's 'waste disposal system' linked to Parkinson's disease

November 14, 2017
An international study has shed new light on the genetic factors associated with Parkinson's disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of ...

Parkinson's disease: A looming pandemic

November 13, 2017
New research shows that the number of people with Parkinson's disease will soon grow to pandemic proportions. In a commentary appearing today in the journal JAMA Neurology, University of Rochester Medical Center neurologist ...

Focused ultrasound shows promise for treating Parkinson's tremor

October 30, 2017
An initial test to determine if a scalpel-free form of brain surgery can reduce tremor caused by Parkinson's disease has produced encouraging results. Further research is warranted, the researchers conclude in a paper published ...

Novel technique explains herbicide's link to Parkinson's disease

October 23, 2017
Northwestern Medicine scientists have used an innovative gene editing technique to identify the genes that may lead to Parkinson's disease after exposure to paraquat, a commonly-used herbicide.

Data, technology drive new approaches to Parkinson's care

October 23, 2017
Complex, multi-system diseases like Parkinson's have long posed challenges to both scientists and physicians. University of Rochester Medical Center (URMC) researchers are now reaching for new tools, such as algorithms, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.